News

Discover all the latest news from Bioprojet: events, updates, innovations… Stay informed about the latest scientific advances and new developments in our therapeutic areas.

#BIONEWS

Bioprojet x CR Sanjiu
Nov 2025

Bioprojet announces the signing of a strategic agreement with CR Sanjiu for the commercialization of WAKIX® in China

Paris, November 7th 2025 — Bioprojet is pleased to announce the conclusion of a major partnership with CR Sanjiu Medical & Pharmaceutical Co., Ltd., a leading player in the Chinese pharmaceutical industry. This agreement grants CR Sanjiu exclusive of WAKIX® (pitolisant) throughout mainland China.

READ

Nov 2025

Central disorders of hypersomnolence : first human clinical trial on BP1.15205

Bioprojet, in partnership with Harmony Biosciences in the United States, has announced the launch of the first human clinical trial of BP1.15205, an orexin type 2 receptor (OX2R) agonist, aimed at treating central disorders of hypersomnolence.

READ

Nov
2025
Nov
2025
November 2025 Events

November 2025 Events

Throughout the month of November, Bioprojet will be attending several congresses in allergology and sleep medicine.

READ

Oct
2025
Oct
2025
Bioprojet will attend the Sleep Congress

Bioprojet will attend the Sleep Congress

Bioprojet will be present at the Sleep Congress 2025, organized by the French Society for Sleep Research and Sleep Medicine and the Sleep Group of the French Language Society of Pulmonology.

READ

Oct
2025
Oct
2025
INSIDE BIOPROJET : Episode 3

INSIDE BIOPROJET : Episode 3

We continue our video series with a new episode, at the heart of our teams, to explore our professions and the people behind them. In this episode, meet Élise Chauvel and Antoine Courban from the Quality Assurance team.

READ

Oct
2025
Oct
2025
October 2025 events

October 2025 events

Throughout June, Bioprojet will be present at several congresses on cardiology, sleep, allergology, and pediatrics.

READ

PAGE 1 SUR 4